MLTX insider buying
Every open-market purchase of MoonLake Immunotherapeutics (MLTX) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$0
Insiders buying (12m)0
Purchases on record1
Last purchase filedOct 9, 2025
No open-market insider purchases of MLTX were reported in the last 12 months. The most recent was filed on Oct 9, 2025: Bodenstedt Matthias (Chief Financial Officer) bought 10,870 shares at $9.09, worth $98.81K.
Get the next MLTX insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll MLTX insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Oct 9 | Bodenstedt MatthiasChief Financial Officer | $98.81K | 10,870 | $9.09 | +2% | Oct 8 | SEC |